Recruiting Angelman Syndrome Studies in Ramat Gan
About Angelman Syndrome Clinical Trials in Ramat Gan
Angelman syndrome is a rare genetic disorder primarily affecting the nervous system, characterized by severe developmental delays, speech impairment, seizures, and a happy demeanor. It is caused by loss of function of the UBE3A gene. Treatment focuses on managing symptoms and maximizing developmental potential.
There are currently 1 angelman syndrome clinical trials recruiting participants in Ramat Gan, . These studies are seeking a combined 70 participants. Research is being sponsored by Ionis Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Angelman Syndrome Clinical Trials in Ramat Gan — FAQ
Are there angelman syndrome clinical trials in Ramat Gan?
Yes, there are 1 angelman syndrome clinical trials currently recruiting in Ramat Gan, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ramat Gan?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ramat Gan research site will contact you about next steps.
Are clinical trials in Ramat Gan free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ramat Gan studies also compensate for your time and travel.
What angelman syndrome treatments are being tested?
The 1 active trials in Ramat Gan are testing new therapies including novel drugs, biologics, and treatment approaches for angelman syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov